Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Journey Medical Corporation (DERM) had Revenue of $13.14M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$13.14M
Net Income	$-4.07M
Cost of Goods Sold	$4.79M
Gross Profit	$8.35M
Operating Expenses	$16.46M
Operating Income	$-3.32M
Non-Operating Income/Expense	$-0.75M
Pre-Tax Income	$-4.07M
Normalized Pre-Tax Income	$-4.07M
Income after Taxes	$-4.07M
Income from Continuous Operations	$-4.07M
Consolidated Net Income/Loss	$-4.07M
Normalized Income after Taxes	$-4.07M
EBIT	$-3.32M
EBITDA	$-2.14M
Weighted-Average Shares Outstanding (Basic)	22.61M
Weighted-Average Shares Outstanding (Diluted)	22.61M
Earnings per Share (EPS) (Basic)	$-0.18
Earnings per Share (EPS) (Diluted)	$-0.18
Balance Sheet Financials
Current Assets	$53.99M
Property, Plant, and Equipment	--
Long-Term Assets	$30.98M
Total Assets	$84.96M
Current Liabilities	$40.22M
Long-Term Debt	$23.11M
Long-Term Liabilities	$23.20M
Total Liabilities	$63.42M
Common Equity	$21.54M
Tangible Shareholders Equity	$-9.26M
Shareholders Equity	$21.54M
Common Shares Outstanding	23.10M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.83M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$3.60M
Beginning Cash	$20.30M
End Cash	$21.07M
Increase/Decrease in Cash	$0.77M
Stock-Based Compensation	$1.32M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.34
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.52
Debt to Equity Ratio	1.16
Gross Margin	63.54%
Operating Margin	-25.30%
EBIT Margin	-25.30%
EBITDA Margin	--
Pre-Tax Profit Margin	-31.00%
Profit Margin	-31.00%
Free Cash Flow	$-2.83M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	0.38
Receiveable Turnover	0.73
Days Sales in Receivables	123.47
Return on Equity	-18.91%
Return on Tangible Equity	44.00%
Return on Assets	-4.79%
Return on Investments	-9.12%
Book Value Per Share	$0.93
Free Cash Flow per Share	$-0.13
Operating Cash Flow per Share	$-0.13

Data from Zacks Investment Research, Inc.